Puma Biotechnology reported $14.28M in EBITDA for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ebitda Change
Agios Pharmaceuticals AGIO:US $ -95.35M 3.32M
Alnylam Pharmaceuticals ALNY:US $ -181.59M 44.32M
Amgen AMGN:US $ 3004M 337M
Biogen BIIB:US $ 1075.7M 401M
Biomarin Pharmaceutical BMRN:US $ 64.42M 7.75M
Bluebird Bio BLUE:US $ -99.42M 19.92M
Cerulean Pharma CERU:US $ -8.4M 1.14M
Clovis Oncology CLVS:US $ -57.48M 9.04M
Daiichi Sankyo 4568:JP Y 49252M 84953M
Esperion Therapeutics ESPR:US $ -52226000 9.39M
Exelixis EXEL:US $ 88.48M 0.75M
Gilead Sciences GILD:US $ 2585M 837M
Glaxosmithkline GSK:US $ 2447M 673M
Intercept Pharmaceuticals ICPT:US $ -10.87M 0.98M
Macrogenics MGNX:US $ -38931000 24.79M
Mirati Therapeutics MRTX:US $ -176.51M 7.08M
Moderna Inc MRNA:US 2.52B 1.78B
Novartis NOVN:VX SF 4660M 108M
Pfizer PFE:US $ 12921M 1739M
Ptc Therapeutics PTCT:US $ -63.18M 2.97M
Puma Biotechnology PBYI:US $ 14.28M 12.77M
Regeneron Pharmaceuticals REGN:US $ 1381.3M 20.4M
Sangamo Biosciences SGMO:US $ -42.85M 0.42M
Sarepta Therapeutics SRPT:US $ -201.24M 125.08M
Seattle Genetics SGEN:US $ -115.89M 0.06M
Takeda 4502:JP Y 308798M 158143M
Ultragenyx Pharmaceutical RARE:US $ -137.11M 4.57M
Vertex Pharmaceuticals VRTX:US $ 1156.6M 87.3M
YTE INCY:US $ 276.8M 132.69M